Abstract
Hepatoma Research is an open access journal and focuses on all topics related to hepatoma. The following articles are especially welcome: pathogenesis, clinical examination and early diagnosis of hepatoma, complications of hepatoma, and their preventions and treatments, etc.
Highlights
The prevalence of nonalcoholic steatohepatitis (NASH)-related hepatocellular carcinoma (HCC) is increasing in parallel with the prevalence of nonalcoholic fatty liver disease (NAFLD), type 2 diabetes mellitus (T2DM) and obesity worldwide, in Western countries[1]
We describe the epidemiology of Hepatocellular carcinoma (HCC) related to metabolic liver disease: NASH-HCC and type 2 diabetes mellitus and obesity-related HCC
While NAFLD can refer to simple steatosis, NASH is characterized by inflammation and is associated with an increased risk of progression to fibrosis, advanced fibrosis, cirrhosis, hepatic decompensation and HCC[13,14]
Summary
The prevalence of nonalcoholic steatohepatitis (NASH)-related hepatocellular carcinoma (HCC) is increasing in parallel with the prevalence of nonalcoholic fatty liver disease (NAFLD), type 2 diabetes mellitus (T2DM) and obesity worldwide, in Western countries[1]. Some new practical guidelines for screening and surveillance of patients with metabolic diseases at risk for HCC are discussed.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
